Shari Gitlin, MD
-
Specialty: Pediatric Palliative Medicine
View Expertise - Languages Spoken: English
Biography: Shari Gitlin, MD
Expertise
Titles
- Assistant Program Director, Pediatrics, UH Rainbow Babies and Children's Hospital
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Hospice and Palliative Medicine - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Education
Fellowship | Pediatric Palliative Care
Pediatric Palliative Care - Children's Hospital Of Philadelphia (2021 - 2022)
Residency | Pediatrics
Pediatrics - Children's Hospital Of Philadelphia (2017 - 2020)
Medical Education
Suny Downstate Medical Center College Of Medicine (2017)
Undergraduate
Cornell University (2011)
About
Shari Gitlin, MD is board certified in pediatrics and hospice and palliative medicine. Dr. Gitlin earned her bachelor’s degree from Cornell University, graduating magna cum laude, and her medical degree from the State University of New York Downstate, in Brooklyn, New York, where she was elected to the Alpha Omega Alpha national medical honor society. She completed her pediatrics residency and hospice and palliative medicine fellowship at Children’s Hospital of Philadelphia. Her academic interests include the development of communication curricula for residents and learners, with a research interest in identifying characteristics of high quality, patient centered communication and optimizing family conferences, while working to reduce health care disparities.
Dr. Gitlin is a member of the American Academy of Hospice and Palliative Medicine and the Association of Pediatric Program Directors.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Shari Gitlin did not disclose any Outside Relationships with Industry.